The prevalence of patients suffering from chronic spontaneous urticaria, in whom omalizumab cannot be stopped even after six years - Schichter-Konfino, V.; Mubariki, R.; Toubi, E.; Vadasz, Z. (Frontiers in Allergy, 2024)